Bardelčíková Annamária, Šoltys Jindřich, Mojžiš Ján
Department of Pharmacology, Medical Faculty of University of Pavol Jozef Šafárik in Košice, Tr. SNP 1, 040 11 Košice, Slovakia.
Institute of Parasitology, Slovak Academy of Science, Hlinkova 3, 040 01 Košice, Slovakia.
Antioxidants (Basel). 2023 Apr 9;12(4):901. doi: 10.3390/antiox12040901.
Colorectal cancer (CRC) represents the second leading cause of cancer-related deaths worldwide. The pathogenesis of CRC is a complex multistep process. Among other factors, inflammation and oxidative stress (OS) have been reported to be involved in the initiation and development of CRC. Although OS plays a vital part in the life of all organisms, its long-term effects on the human body may be involved in the development of different chronic diseases, including cancer diseases. Chronic OS can lead to the oxidation of biomolecules (nucleic acids, lipids and proteins) or the activation of inflammatory signaling pathways, resulting in the activation of several transcription factors or the dysregulation of gene and protein expression followed by tumor initiation or cancer cell survival. In addition, it is well known that chronic intestinal diseases such as inflammatory bowel disease (IBD) are associated with an increased risk of cancer, and a link between OS and IBD initiation and progression has been reported. This review focuses on the role of oxidative stress as a causative agent of inflammation in colorectal cancer.
结直肠癌(CRC)是全球癌症相关死亡的第二大主要原因。CRC的发病机制是一个复杂的多步骤过程。在其他因素中,炎症和氧化应激(OS)据报道参与了CRC的发生和发展。尽管OS在所有生物体的生命中起着至关重要的作用,但其对人体的长期影响可能与包括癌症疾病在内的不同慢性疾病的发展有关。慢性OS可导致生物分子(核酸、脂质和蛋白质)氧化或炎症信号通路激活,导致多种转录因子激活或基因和蛋白质表达失调,随后引发肿瘤或癌细胞存活。此外,众所周知,慢性肠道疾病如炎症性肠病(IBD)与癌症风险增加有关,并且有报道称OS与IBD的发生和进展之间存在联系。本综述重点关注氧化应激作为结直肠癌炎症致病因素的作用。
Antioxidants (Basel). 2023-4-9
World J Gastroenterol. 2014-12-28
World J Gastrointest Oncol. 2022-3-15
Hered Cancer Clin Pract. 2019-7-12
World J Gastroenterol. 2014-8-7
Curr Opin Pharmacol. 2009-7-7
Int J Mol Sci. 2025-8-20
Antioxidants (Basel). 2025-8-4
Diabetol Metab Syndr. 2025-7-18
Antioxidants (Basel). 2025-6-15
World J Gastrointest Oncol. 2025-6-15
Technol Cancer Res Treat. 2022
World J Gastroenterol. 2022-8-14
Cancer Cell Int. 2022-8-16
Cell Commun Signal. 2022-6-30
Cancer Metastasis Rev. 2022-6
CA Cancer J Clin. 2022-1
Can J Infect Dis Med Microbiol. 2021-11-9